Alzamend Neuro ALZN
NASDAQ ALZN
$1.67 -0.04 (-2.34%)
As of: Sep 10, 2026 · 12:03 PM EDT

Alzamend Neuro (ALZN) Prepaid Assets (2020 - 2026)

Alzamend Neuro's (ALZN) quarterly Prepaid Assets came in at $1.1 million in Q2 2026, up 360.74% year-over-year from $228719.0 in Q2 2025, and up 6.86% quarter-over-quarter from $986143.0 in Q1 2026.

Analysis

Alzamend Neuro (ALZN) Prepaid Assets (2020 - 2026) Analysis & Trends

Alzamend Neuro has disclosed Prepaid Assets across 7 years of filings, most recently posting $1.1 million for Q2 2026.

  • In Q2 2026, Prepaid Assets rose 360.74% year-over-year to $1.1 million; the TTM figure through Apr 2026 stood at $1.1 million (up 360.74% YoY), while the FY2026 annual figure was $1.1 million, up 360.74% from the prior year.
  • Prepaid Assets came in at $1.1 million for Q2 2026 at Alzamend Neuro, up from $986143.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.1 million in Q2 2026 to a low of $79194.0 in Q2 2024.
  • Average Prepaid Assets over 5 years is $518648.2, with a median of $564052.5 recorded in 2023.
  • Year-over-year, Prepaid Assets tumbled 82.31% in 2024 and jumped 360.74% in 2026.
  • Over 5 years, Prepaid Assets stood at $742001.0 in 2022, then fell by 21.59% to $581802.0 in 2023, then gained by 15.79% to $673669.0 in 2024, then plunged by 59.62% to $272015.0 in 2025, then surged by 287.41% to $1.1 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $1.1 million in Q2 2026, $986143.0 in Q1 2026, and $272015.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.51 Bn 192.52 Bn 7.24 Bn
2 Gilead Sciences 179.28 Bn 176.11 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.06 Bn 123.21 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.61 Bn 73.62 Bn 3.93 Bn
5 Argenx Se 60.71 Bn 55.52 Bn 1.37 Bn
6 Moderna 53.60 Bn 48.46 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.41 Bn 30.10 Bn 992.69 Mn
8 Biogen 31.79 Bn 30.50 Bn 1.96 Bn
9 Roivant Sciences 29.11 Bn 29.11 Bn 1.16 Mn
10 Alzamend Neuro 5.57 Mn 5.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 1.05 Mn
Jan 31, 2026 986,143.00
Oct 31, 2025 272,015.00
Jul 31, 2025 307,958.00
Apr 30, 2025 228,719.00
Jan 31, 2025 589,208.00
Oct 31, 2024 673,669.00
Jul 31, 2024 222,241.00
Apr 30, 2024 79,194.00
Jan 31, 2024 310,738.00
Oct 31, 2023 581,802.00
Jul 31, 2023 718,188.00
Apr 30, 2023 447,589.00
Jan 31, 2023 546,303.00
Oct 31, 2022 742,001.00
Jul 31, 2022 587,542.00
Apr 30, 2022 349,723.00
Jan 31, 2022 638,827.00
Oct 31, 2021 928,204.00
Jul 31, 2021 349,723.00